Immunic, Inc.
IMUX· Nasdaq
IMUXImmunic, Inc.
Filed Aug 7, 2014 · 10-Q · 38 days after period end · 0001193125-14-298850
| Metric | Q2 2014 | Q2 2013 |
|---|---|---|
| Net Income | -$10.17M | -$6.14M |
| EPS Diluted | -$0.91 | -$14.33 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR
ended Jun 30, 2014 · filed Aug 7, 2014 · 38 d after period end
